Urotensin II levels in patients with inflammatory bowel disease

Table 2 Laboratory parameters of the inflammatory bowel disease group and the control group

Parameter	IBD group (n = 50)	Control group (n = 50)	P value1
Erythrocytes (× 1012/L)	4.7 ± 0.5	5.0 ± 0.4	0.020
Hemoglobin (g/L)	140.4 ± 17.3	148.1 ± 13.7	0.015
Fasting glucose (mmol/L)	5.1 ± 0.9	5.0 ± 0.6	0.653
Urea (mmol/L)	4.7 ± 1.5	5.6 ± 1.6	0.004
Creatinine (μmol/L)	71.4 ± 15.3	75.9 ± 14.7	0.134
Total proteins (g/L)	71.2 ± 6.6	72.1 ± 3.9	0.394
Albumins (g/L)	39.5 ± 5.1	43.7 ± 2.4	< 0.001
hsCRP (mg/L)	3.4 ± 2.6	1.2 ± 1.1	< 0.001
Triglycerides (mmol/L)	1.3 ± 0.9	1.1 ± 0.6	0.311
Total cholesterol (mmol/L)	4.8 ± 1.3	5.2 ± 1.2	0.091
HDL cholesterol (mmol/L)	1.3 ± 0.4	1.4 ± 0.3	0.447
LDL cholesterol (mmol/L)	2.6 (2.1-3.4)	3.2 (2.4-3.9)	0.018
FC (μg/g)	231 (61.5-619.2)	-	-

¹t-test for independent samples or Mann-Whitney U test.

FC: Fecal calprotectin; HDL: High-density lipoprotein; HsCRP: High sensitivity C-reactive protein; LDL: Low-density lipoprotein. Data are presented as mean ± SD and median (interquartile range).